Literature DB >> 16979636

Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure.

Wendy J Watkins1, Alexandra J Umbers, Kathryn J Woad, Sarah E Harris, Ingrid M Winship, Ksenija Gersak, Andrew N Shelling.   

Abstract

FOXO3A and FOXO1A are excellent candidate genes for the development of premature ovarian failure and have not been analyzed previously in POF patients. Potentially causal mutations in FOXO3A (2/90; 2.2%) and FOXO1A (1/90; 1.1%) were identified in POF patients; however, the pathological role of these mutations will be determined only by screening increased numbers of patients and controls, or by functional studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979636     DOI: 10.1016/j.fertnstert.2006.03.054

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  34 in total

1.  FOXO3 gene variants and human aging: coding variants may not be key players.

Authors:  Timothy A Donlon; J David Curb; Qimei He; John S Grove; Kamal H Masaki; Beatriz Rodriguez; Ayako Elliott; D Craig Willcox; Bradley J Willcox
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-28       Impact factor: 6.053

Review 2.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  Specificity of the requirement for Foxo3 in primordial follicle activation.

Authors:  George B John; Lane J Shirley; Teresa D Gallardo; Diego H Castrillon
Journal:  Reproduction       Date:  2007-05       Impact factor: 3.906

4.  Mutation analysis of NANOS3 in 80 Chinese and 88 Caucasian women with premature ovarian failure.

Authors:  Yingying Qin; Han Zhao; Ertug Kovanci; Joe Leigh Simpson; Zi-Jiang Chen; Aleksandar Rajkovic
Journal:  Fertil Steril       Date:  2007-04-05       Impact factor: 7.329

Review 5.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

Review 6.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

7.  Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea.

Authors:  Teresa D Gallardo; George B John; Karen Bradshaw; Corrine Welt; Renee Reijo-Pera; Peter H Vogt; Philippe Touraine; Silvia Bione; Daniela Toniolo; Lawrence M Nelson; Andrew R Zinn; Diego H Castrillon
Journal:  Hum Reprod       Date:  2007-10-23       Impact factor: 6.918

Review 8.  A fork in the path: Developing therapeutic inroads with FoxO proteins.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  Oxid Med Cell Longev       Date:  2009 Jul-Aug       Impact factor: 6.543

9.  Gonadal expression of Foxo1, but not Foxo3, is conserved in diverse Mammalian species.

Authors:  Edward D Tarnawa; Michael D Baker; Gina M Aloisio; Bruce R Carr; Diego H Castrillon
Journal:  Biol Reprod       Date:  2013-04-25       Impact factor: 4.285

Review 10.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.